Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

Human Oncostatin M Recombinant

Recombinant Oncostatin-M is a disulfide-linked homodimeric protein consisting of 228 amino acid residues, and migrates as an approximately 26 kDa protein under non-reducing and reducing conditions in SDS-PAGE. Optimized DNA sequence encoding Human Oncostatin-M mature chain was expressed inE. coli.

Product Specifications

Background

Oncostatin M is produced by monocytes and T-cells after cell activation, adherent macrophages, and various T- cell lines. Oncostatin M is a member of the IL-6-related cytokine subfamily that includes IL-6, IL-11, LIF, CNTF and CT-1. Oncostatin M mediates its bioactivities through two different heterodimer receptors. They both involve gp130 as a signal transducing moiety, which is found also in receptors for a number of other cytokines. When gp130 dimerizes with LIF receptor beta subunit this generates the high affinity type 1 OSM receptor. When gp130 dimerizes with a protein known as OSM receptor beta this generates the type 2 OSM receptor. Both OSM receptors activate the receptor-associated Janus kinases JAK1, JAK2, and TYK2. Signaling also involves the transcriptional activators STAT3 and STAT5b. was specifically activated through the gp130-OSM-R-beta type II heterocomplex. The signaling pathway differences observed between the common type I LIF/OSM receptor and the specific type II OSM receptor might explain some of the bioactivities specifically displayed by OSM. Oncostatin M inhibits the growth of several tumor cell lines (A375 melanoma, lung carcinomas) . The antiproliferative activity of oncostatin M for some cell lines is synergised by TGF-beta and IFN-gamma. It promotes the growth of human fibroblasts, vascular smooth muscle cells, and some normal cell lines. Oncostatin can inhibit the proliferation of murine M1 myeloid leukemic cells and induces their differentiation into macrophage-like cells, a function shared by LIF, G-CSF, and IL-6.

UniProt

P13725

Endotoxin

< 0.1 ng/µg (1 EU/µg), using the LAL gel clot method.

Purity

≥ 95% by SDS-PAGE and HPLC

Format

Lyophilized protein

Reconstitution

Reconstitute at 0.1-1.0 mg/ml in distilled water. This solution can then be diluted into other buffers. To maximize product collection from vial surface, vortex briefly and then spin down to recollect the liquid.

Shipping Conditions

Gel Packs or Dry Ice

Storage Conditions

The lyophilized protein is stable for at least 2 years from date of receipt when stored at -20°C. Upon reconstitution, store in working aliquots at +4°C for up to one month, or at -20°C for up to six months, in the presence of a carrier protein. Avoid repeated freeze/thaw cycles.

Calculated Molecular Weight

26 kDa

Formulation

Lyophilized from a 0.2 µm filtered concentrated (1 mg/ml) PBS solution, pH 7.0.

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

MTX1 Antibody - C-terminal region : Biotin (ARP45315_P050-Biotin)
ARP45315_P050-Biotin 100 µL

MTX1 Antibody - C-terminal region : Biotin (ARP45315_P050-Biotin)

Ask
View Details
SingleFlowEx CD45RA PE-DyLight™ 594
ED7577 1 mL

SingleFlowEx CD45RA PE-DyLight™ 594

Ask
View Details
NPC1 Double Nickase Plasmid (m)
sc-421941-NIC 20 µg

NPC1 Double Nickase Plasmid (m)

Ask
View Details
Inhibitor mmu-miR-503-5p AAV miRNA Vector
Amm3083000 500 ng

Inhibitor mmu-miR-503-5p AAV miRNA Vector

Ask
View Details
Recombinant Dog Islet amyloid polypeptide (IAPP)
MBS954509-01 0.05 mg (E-Coli)

Recombinant Dog Islet amyloid polypeptide (IAPP)

Ask
View Details
Recombinant Dog Islet amyloid polypeptide (IAPP)
MBS954509-02 0.2 mg (E-Coli)

Recombinant Dog Islet amyloid polypeptide (IAPP)

Ask
View Details